A tailored course, built for your situation
Production-Grade AI in Pharmaceutical R&D Operations for Audit Teams
Mastering compliant, scalable AI systems for modern drug development oversight
The situation this course is for
As AI accelerates target discovery, trial design, and safety analysis, audit functions struggle to assess model integrity, data provenance, and change control. Traditional audit approaches don't scale to dynamic AI systems, creating delays, rework, and compliance uncertainty.
Who this is for
Compliance officers, audit leads, quality assurance managers, and technology risk professionals in pharmaceutical or biotech organizations overseeing AI use in R&D.
Who this is not for
This course is not for data scientists building models or executives seeking high-level AI overviews.
What you walk away with
- Apply audit principles to AI model lifecycle stages in R&D
- Evaluate production-readiness of AI systems using industry benchmarks
- Document model governance for regulatory review
- Implement change control protocols for AI pipelines
- Lead cross-functional alignment between data science and audit teams
The 12 modules (with all 144 chapters)
- Introduction to AI in pharma R&D
- Regulatory context for AI oversight
- Key audit touchpoints in AI workflows
- Case study: AI in preclinical target identification
- Case study: AI in clinical trial design
- Emerging standards for AI validation
- Audit team roles in AI governance
- Stakeholder mapping in R&D AI projects
- Risk assessment frameworks for AI systems
- Documentation expectations for auditors
- Common gaps in AI project transparency
- Preparing for AI audit engagement
- What 'production-grade' means in pharma
- System reliability and uptime expectations
- Model versioning and reproducibility
- Data pipeline integrity controls
- Monitoring for model drift and decay
- Failover and rollback procedures
- Audit logging requirements
- Access control and role-based permissions
- System validation under GxP
- Change management for AI components
- Integration with legacy R&D systems
- Performance benchmarking for audit
- Phased model development in pharma
- Gate reviews and audit checkpoints
- Documentation standards at each stage
- Version control for models and code
- Data lineage from source to inference
- Validation of training data quality
- Bias and fairness assessment protocols
- Model interpretability techniques
- Third-party model sourcing controls
- Vendor oversight in AI pipelines
- Model handoff from science to ops
- Audit trail completeness verification
- GxP data requirements for AI
- ALCOA+ principles in AI contexts
- Data ownership and stewardship models
- Metadata standards for AI datasets
- Data anonymization and privacy controls
- Audit trails for data transformations
- Handling raw vs. processed data
- Data retention and archival rules
- Cross-border data transfer considerations
- Data quality dashboards for auditors
- Reconciling data across systems
- Auditing data pipelines for completeness
- Validation vs. verification in AI
- Developing a validation strategy
- Test case design for AI models
- Performance metric selection and thresholds
- Statistical validation techniques
- Clinical relevance assessment
- Sensitivity and robustness testing
- Validation under edge cases
- Documentation of validation results
- Revalidation triggers and schedules
- Third-party validation oversight
- Audit readiness of validation packages
- Change control in AI model lifecycle
- Impact assessment for model updates
- Approval workflows for AI changes
- Rollback planning and testing
- Version synchronization across environments
- Configuration drift detection
- Patch management for AI dependencies
- Emergency change protocols
- Audit logging of change events
- Post-change validation requirements
- Change notification to stakeholders
- Audit review of change control records
- Real-time model performance tracking
- Drift detection algorithms and thresholds
- Alerting and escalation procedures
- Performance dashboards for audit review
- Scheduled model re-evaluation
- Feedback loops from clinical outcomes
- Handling model degradation
- Incident response for AI failures
- Root cause analysis for model issues
- Audit trails for monitoring activities
- Benchmarking against historical performance
- Reporting model health to audit teams
- FDA and EMA expectations for AI
- Aligning with ICH guidelines
- Preparing for AI-focused inspections
- Common inspection findings in AI
- Response protocols for regulatory queries
- Document organization for audits
- Mock audit exercises for AI systems
- Gap assessment against regulatory standards
- Corrective action plans for AI
- Regulatory communication strategies
- Post-inspection follow-up
- Maintaining inspection readiness
- Governance committee structures
- RACI matrices for AI projects
- Communication protocols across teams
- Joint review meetings and cadence
- Conflict resolution in AI decisions
- Shared documentation platforms
- Training for cross-functional awareness
- Escalation paths for audit concerns
- Feedback integration from auditors
- Balancing innovation and compliance
- Metrics for governance effectiveness
- Auditor participation in governance
- Required documentation artifacts
- Standard operating procedures for AI
- Model cards and system documentation
- Data dictionaries and lineage maps
- Validation reports and summaries
- Change logs and audit trails
- User manuals and training materials
- Risk assessment documentation
- Compliance checklists for AI
- Document version control
- Retention schedules for AI records
- Preparing documentation for inspection
- AI-specific risk categories
- Risk assessment methodologies
- Control design for AI risks
- Third-party risk in AI supply chain
- Cybersecurity considerations for AI
- Business continuity for AI systems
- Insurance and liability considerations
- Internal audit planning for AI
- External assurance of AI systems
- Reporting AI risk to leadership
- Risk heat mapping for R&D AI
- Audit testing of risk controls
- Emerging AI techniques in pharma
- Generative AI and its audit implications
- Federated learning and data privacy
- AI in real-world evidence generation
- Autonomous decision-making systems
- Ethical AI frameworks in healthcare
- Global regulatory trends
- Scalability challenges for audit
- Automation of audit processes
- AI literacy for audit teams
- Long-term governance strategy
- Sustaining audit relevance in AI era
How this maps to your situation
- Auditing AI in preclinical research
- Validating AI models for clinical trials
- Reviewing vendor-developed AI tools
- Preparing for regulatory inspection of AI systems
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 60, 70 hours of focused learning, designed for completion over 8, 10 weeks with flexible pacing.
How this compares to the alternatives
Unlike generic AI ethics courses or technical data science programs, this course is specifically tailored to audit and compliance professionals in pharmaceutical R&D, offering implementation-grade detail on validation, documentation, and regulatory alignment.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.